- Q3 2023 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2023$2.84 (+2.90%)Earnings
- Ocular Therapeutix Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2023$4.36 (-3.33%)Earnings
- Ocular Therapeutix Inc To Discuss the 12-Month Data TranscriptJun 12, 2023
- Ocular Therapeutix Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Ocular Therapeutix Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2023$6.4 (+2.40%)Earnings
- Q4 2022 Ocular Therapeutix Inc Earnings Call TranscriptMar 06, 2023$5.58 (-5.58%)Earnings
- Ocular Therapeutix Inc To Discuss Interim Data Update Call TranscriptFeb 13, 2023
- Q3 2022 Ocular Therapeutix Inc Earnings Call TranscriptNov 07, 2022$3.55 (+1.43%)Earnings
- Ocular Therapeutix Inc Corporate Call TranscriptSep 27, 2022
- Q2 2022 Ocular Therapeutix Inc Earnings Call TranscriptAug 08, 2022$5.06 (+2.02%)Earnings
- Q1 2022 Ocular Therapeutix Inc Earnings Call TranscriptMay 09, 2022$3.26 (-6.05%)Earnings
- Q4 2021 Ocular Therapeutix Inc Earnings Call TranscriptFeb 28, 2022$5.58 (+1.09%)Earnings
- Ocular Therapeutix Inc to Discuss Results From Its Phase 2 Clinical Trial of OTX-DED Call TranscriptDec 06, 2021
- Q3 2021 Ocular Therapeutix Inc Earnings Call TranscriptNov 08, 2021$7.1 (+1.87%)Earnings
- Q2 2021 Ocular Therapeutix Inc Earnings Call TranscriptAug 09, 2021$10.73 (+1.90%)Earnings
- Q1 2021 Ocular Therapeutix Inc Earnings Call TranscriptMay 05, 2021$16.56 (-0.96%)Earnings
- Q4 2020 Ocular Therapeutix Inc Earnings Call TranscriptMar 11, 2021$20.31 (+3.31%)Earnings
- Ocular Therapeutix Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q3 2020 Ocular Therapeutix Inc Earnings Call TranscriptNov 05, 2020$12 (-0.41%)Earnings
- Q2 2020 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2020$8.21 (-2.96%)Earnings
- Ocular Therapeutix Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q1 2020 Ocular Therapeutix Inc Earnings Call TranscriptMay 08, 2020$5.97 (-10.09%)Earnings
- Ocular Therapeutix Inc - Announces Results Of Phase 3 Clinical Trial of Dextenza TranscriptApr 28, 2020
- Q4 2019 Ocular Therapeutix Inc Earnings Call TranscriptMar 12, 2020$4.29 (-19.81%)Earnings
- Q3 2019 Ocular Therapeutix Inc Earnings Call TranscriptNov 12, 2019$2.57 (-12.29%)Earnings
- Q2 2019 Ocular Therapeutix Inc Earnings Call TranscriptAug 07, 2019$4.57 (-1.51%)Earnings
- Q1 2019 Ocular Therapeutix Inc Earnings Call TranscriptMay 10, 2019$3.68 (+0.55%)Earnings
- Ocular Therapeutix Inc Research & Development Day TranscriptMar 28, 2019
- Q4 2018 Ocular Therapeutix Inc Earnings Call TranscriptMar 07, 2019$4.38 (+1.86%)Earnings
Ocular Therapeutix Inc To Discuss the 12-Month Data Transcript
Good day, and welcome to the Ocular Therapeutix conference call announcing 12-month data from the U.S.-based Phase I clinical trial evaluating OTX-TKI for the treatment of wet AMD.
(Operator Instructions)
As a reminder, this call may be recorded. I would now like to turn the call over to Antony Mattessich, Chief Executive Officer. You may begin.
Well, hello, and thanks for attending the Ocular Therapeutix press conference for our 12-week top line data or OTX-TKI. Let me start first by emphasizing how encouraged and excited we are with this data as it continues to support our product's profile and the potential to set the standard of care of durability in wet AMD, which is the highest unmet need in the space.
I'll be very brief and get directly to Dr. Arshad Khanani. Transitioning to Arshad is important not only because the he will be presenting the data, but also because Arshad is our largest enroller, has by far the most clinical experience treating
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)